We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

When Science Leaves the Lab, Microscopy Goes Portable
Blog

Microscopy is a key tool in many areas of research, but what happens when what you want to study is in a remote location, doesn’t transport well or you need instant answers? Well, then the analysis has to go to the sample. We spoke to Andrew Monk, cofounder of ioLight, about ioLight’s conception and what makes it so special.

Read More

The Steps to Creating a Materials Informatics Strategy
Blog

Data has been called the crucial raw material of the 21st century. As such, materials companies are waking up to the importance of having an informatics strategy. We caught up with Lux Research's Xiao Zhong, Ph.D., who recently authored a report explaining the key steps in creating a materials informatics strategy, to find out more.

Read More

Wellness and Illness From a Precision Quantification Perspective
Blog

In this interview, Aaron Hudson, Vice President & General Manager, Global Marketing & Strategy at SCIEX, discusses why precision quantification, specifically quantitative mass spectrometry (MS), is the best approach for measuring the transition from "wellness" to illness.

Read More

A Step Towards Democratization in Mass Spectrometry: Agilent Launch Novel "Self-aware" Mass Detector
Blog

How can vendors ensure their technologies are less complex, and therefore available to a wider range of users, without compromising on the quality of data?

Read More

Advancing Robotic and Automation Technologies to Improve Human Health
Blog

Robotic and automation technologies are advancing at a staggering rate, and the introduction of collaborative robots has fundamentally changed the way scientists coexist with automated systems.. Ira Hoffman, CEO at HighRes Biosolutions® tells us about the company’s mission to “improve human health through life science robotics”.

Read More

Maximizing Drug Discovery Success With Machine Learning
Blog

The pipeline to new drugs isn’t straightforward, but pharmas can pool their data resources to speed things up. The MELLODDY consortium hopes to make data sharing simple and secure. We talked to Hugo Ceulemans, MELLODDY Project Leader and Mathieu Galtier, Project Coordinator at Owkin to find out more.

Read More

Imagine Collaboration, Without the Faff
Blog

Imagine if there was a better way to write, format, and review scientific manuscripts for publication. doDOC Document Collaboration Expert Leif Måsvær believes there is. Leif explains how this cloud-based platform is a game-changer that overcomes the major obstacles present during the authoring, writing, and reviewing process.

Read More

Screening Living Cells at High Speed
Blog

We recently spoke with Eric Hobbs, CEO at Berkeley Lights to learn more about "digital cell biology". Eric also describes how optofluidics can be used to gain fast, comprehensive measurements and insights across thousands of cells in parallel.

Read More

Uniting Stakeholders To Streamline Drug Discovery
Blog

We recently spoke with Tyler Golato, Lead Scientist at Molecule, to learn more about the "innovation crisis", the factors directly impacting the types of therapeutics being brought to market, and how by uniting stakeholders it is possible to streamline the drug development pipeline.

Read More

DNA and RNA: Why It’s All About Integrity
Blog

In this interview, we spoke with Knut Wintergerst, PhD, General Manager of Biomolecular Systems and Solutions (BSS) and Diagnostics and Genomics Group (DGG) at Agilent to learn more about why DNA and RNA sample integrity is important to scientists and how it can be maintained and analyzed.

Read More